Olmesartan/Hydrochlorothiazid Heumann (Olmesartan Medoxomil, Hydrochlorothiazide)

Olmesartan medoxil, the active ingredient in Olmesartan/Hydrochlorothiazid Heumann, is an angiotensin II receptor blocker (ARB) presented as a tablet for oral use. It treats hypertension, often in combination with a diuretic, and is intended for adult patients. GNH USA supplies Olmesartan/Hydrochlorothiazid Heumann as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmesartan/Hydrochlorothiazid Heumann as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olmesartan/Hydrochlorothiazid Heumann is an antihypertensive medication that acts on the renin‑angiotensin‑aldosterone system to lower blood pressure.

- Hypertension: improves blood pressure control when used alone or with other agents. - Heart failure: assists the management of fluid overload when combined with other heart‑failure therapies. - Diabetic nephropathy : slows the progression of kidney damage associated with type 2 diabetes. - Post‑cardiac surgery recovery : provides additional blood‑pressure control during conval period. - Chronic kidney disease : helps manage elevated blood pressure in patients with reduced renal function. - Stroke   ":[     "  "  ""  "